Navigation Links
New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy

as a result of new information, future developments or otherwise.

CONTACT: Media, Danielle Halstrom, +1-484-865-2020, or Natalie de Vane,+1-484-865-5139, both of Wyeth Pharmaceuticals; or Investors, JustinVictoria of Wyeth, +1-973-660-5340

Web site: http://www.wyeth.com/

Ticker Symbol: (NYSE:WYE)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
7. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
10. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
11. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
Post Your Comments:
(Date:10/10/2008)..., Oct. 10 /- Boston Scienti...schedule of the Company,s major,events and press a...tion,s,(CRF) twentieth annual Transcatheter Cardio...which runs from October 12 to 17 in Washington, D....ange of safety and,efficacy data on its TAXUS(R) E...
(Date:10/9/2008)...s for Increased Sales and Marketing Efforts to Acc...ip(R) System, MENLO PARK, Calif., Oct. 9 /PRNewsw...t of devices for the percutaneous repair of cardia...cutive team with the appointment of,Sean Cleary as...eting and,Chris Richardson, as vice president of s...
(Date:10/8/2008)...a., Oct. 8 /PRNewswire-USNewswire/ -- The facts ar... from HIV/AIDS in,sub-Saharan Africa. More than 35...frica have already died of AIDS. The Foundation fo...ure the dying and their families,find compassion a...,s,innovative partnering initiative links African ...
(Date:10/8/2008)...ab Program to be Discontinued and Headcount to be ...its Portfolio Review; Zanolimumab Program to be D... of Employees, COPE... A/S (OMX: GEN),announced today that it is discont...In addition, as a result of a portfolio review and...
Breaking Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 1The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 2The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 3The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 4The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 5The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 6New knock out gene model provides molecular clues to breast cancer 615 1New knock out gene model provides molecular clues to breast cancer 615 2New knock out gene model provides molecular clues to breast cancer 615 3Martek Announces Third Quarter 2007 Financial Results 613 1Martek Announces Third Quarter 2007 Financial Results 613 2Martek Announces Third Quarter 2007 Financial Results 613 3Martek Announces Third Quarter 2007 Financial Results 613 4Martek Announces Third Quarter 2007 Financial Results 613 5Martek Announces Third Quarter 2007 Financial Results 613 6Martek Announces Third Quarter 2007 Financial Results 613 7Martek Announces Third Quarter 2007 Financial Results 613 8Martek Announces Third Quarter 2007 Financial Results 613 9Martek Announces Third Quarter 2007 Financial Results 613 10Martek Announces Third Quarter 2007 Financial Results 613 11Martek Announces Third Quarter 2007 Financial Results 613 12IRIDEX Announces Closing of 245 0 Million Private Placement 608 1IRIDEX Announces Closing of 245 0 Million Private Placement 608 2IRIDEX Announces Closing of 245 0 Million Private Placement 608 3IRIDEX Announces Closing of 245 0 Million Private Placement 608 4
...akthrough Will Aid in Developing Therapies to Prev...RYVILLE, Calif., May 10, 2007 /PRNewswire/ -- Kine...lopment company, announced,today the first method ...es in animals through the pathway known as reverse...n mechanism by which excess,cholesterol can be rem...
...POLIS, France, May 11, 2007 /PRNewswire-FirstCall/...pdate on the phase 2a,study for NCX 1000, which is... Pharma Inc. A preliminary analysis of 11 patient...tension confirmed,the safety profile of NCX 1000 b...pport the continuation of this clinical trial. As ...
Other Medicine Technology:KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
... the womb! Mothers can prevent the occurrence of c...e course of life //just by having a nutritious die...vegetables like cabbage and broccoli. A new study ...titute at Oregon State University, done with labor...
...nics were developed by scientists with a vision to... all defective genes from the gene pool. // But no...ade to order. Though it sounds absurd, ‘why should...To some parents with disabilities like deafness an...
...indicated that blood tests which were designed to ... good //as cholesterol tests , or blood pressure t... veritable risk indicator. Doctors have been mak...d which they interpreted as indicators of a heart ...
..., effectiveness and reliability of LASIK and LASEK...etween the two types of laser eye// surgery. The ...researcher, is published in the December 2006 issu...f Ophthalmology. "Although there have been many s...
Other Medicine News:Health News:Cancer Prevention Begins During Pregnancy 2Health News:Cancer Prevention Begins During Pregnancy 3Health News:Can Defective Babies Be Made To Order? 2Health News:Study Compares LASIK and LASEK Eye Surgery 2
Gentamicin Reagent Solution (10 mg/ml) liquid
LB Agar plates with 0.1mM EDTA.
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride.
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride.
Medicine Products: